XML 17 R29.htm IDEA: XBRL DOCUMENT v3.20.1
Note 23 - Covid-19
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Covid-19 [Text Block]
23.
   COVID-
19
 
Our business and results of operations
may
be negatively impacted by the spread of COVID-
19.
 
We sell our products throughout the United States and in many foreign countries and
may
be impacted by public health crises beyond our control. This could disrupt our operations and negatively impact sales of our products. Our customers, suppliers and distributors
may
experience similar disruption. In
December 2019,
COVID-
19
was reported in Wuhan, China. The World Health Organization has since declared the outbreak to constitute a pandemic. The extent of the impact of COVID-
19
on our operational and financial performance will depend on certain developments, including the duration and spread of the outbreak, the impact on our customers and employees, all of which are uncertain and cannot be predicted. The preventative and protective actions that governments have taken to counter the effects of COVID-
19
have resulted in a period of business disruption, including delays in shipments of products and raw materials. To the extent the impact of COVID-
19
continues or worsens, the demand for our products
may
be negatively impacted, and we
may
have difficulty obtaining the materials necessary for the production of our products. In addition, the production facilities of our suppliers
may
be closed for sustained periods of time and industry-wide shipment of products
may
be negatively impacted. COVID-
19
has also delayed certain strategic transactions the Company intended to close on in the near future and the Company does
not
know if and when such transactions will be completed.